c-IAP1 and c-IAP2 Are Critical Mediators of Tumor Necrosis Factor α (TNFα)-induced NF-κB Activation
Eugene Varfolomeev(Molecular Oncology (United States)), Domagoj Vucic(Gene Therapy Laboratory)
Cited by 536
Related Papers
RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury
|Cell Death and Differentiation|2016|439
The Balance of TNF Mediated Pathways Regulates Inflammatory Cell Death Signaling in Healthy and Diseased Tissues
|Frontiers in Cell and Developmental Biology|2020|359
c‐IAP1 and UbcH5 promote K11‐linked polyubiquitination of RIP1 in TNF signalling
|The EMBO Journal|2010|338
Molecular Determinants of Kinase Pathway Activation by Apo2 Ligand/Tumor Necrosis Factor-related Apoptosis-inducing Ligand
|Journal of Biological Chemistry|2005|274
RIP1 inhibition blocks inflammatory diseases but not tumor growth or metastases
|Cell Death and Differentiation|2019|145